Original Article

Neuropsychopharmacology (2005) 30, 1269–1277, advance online publication, 9 February 2005; doi:10.1038/sj.npp.1300686

Preclinical Research

Effects of Acute and Long-Term Administration of Escitalopram and Citalopram on Serotonin Neurotransmission: an In Vivo Electrophysiological Study in Rat Brain

Mostafa El Mansari1,3, Connie Sánchez2, Guy Chouvet1, Bernard Renaud1 and Nasser Haddjeri1

  1. 1Laboratory of Neuropharmacology and Neurochemistry, Faculty of Pharmacy, University of Claude Bernard Lyon I, Lyon Cedex, France
  2. 2Neuropharmacological Research, H Lundbeck A/S, Valby, Denmark

Correspondence: Dr N Haddjeri, Laboratory of Neuropharmacology and Neurochemistry, Faculty of Pharmacy, Claude Bernard University, INSERM U-512, 8, Avenue Rockefeller, 69373 Lyon Cedex 08, France. Tel: +33 4 78 77 75 54; Fax: +33 4 78 77 72 09; E-mail: nhaddj@rockefeller.univ-lyon1.fr

3Present address: Institute of Mental Health Research, University of Ottawa, Lady Grey Bldg, 1145 Carling Avenue, Ottawa, Ontario, Canada K17 7K4.

Received 20 August 2004; Revised 20 December 2004; Accepted 21 December 2004; Published online 9 February 2005.

Top

Abstract

The present study was undertaken to compare the acute and long-term effects of escitalopram and citalopram on rat brain 5-HT neurotransmission, using electrophysiological techniques. In hippocampus, after 2 weeks of treatment with escitalopram (10 mg/kg/day, s.c.) or citalopram (20 mg/kg/day, s.c.), the administration of the selective 5-HT1A receptor antagonist WAY-100,635 (20–100 mug/kg, i.v.) dose-dependently induced a similar increase in the firing activity of dorsal hippocampus CA3 pyramidal neurons, thus revealing direct functional evidence of an enhanced tonic activation of postsynaptic 5-HT1A receptors. In dorsal raphe nucleus, escitalopram was four times more potent than citalopram in suppressing the firing activity of presumed 5-HT neurons (ED50=58 and 254 mug/kg, i.v., respectively). Interestingly, the suppressant effect of escitalopram (100 mug/kg, i.v.) was significantly prevented, but not reversed by R-citalopram (250 mug/kg, i.v.). Sustained administration of escitalopram and citalopram significantly decreased the spontaneous firing activity of presumed 5-HT neurons. This firing activity returned to control rate after 2 weeks in rats treated with escitalopram, but only after 3 weeks using citalopram, and was associated with a desensitization of somatodendritic 5-HT1A autoreceptors. These results suggest that the time course of the gradual return of presumed 5-HT neuronal firing activity, which was reported to account for the delayed effect of SSRI on 5-HT transmission, is congruent with the earlier onset of action of escitalopram vs citalopram in validated animal models of depression and anxiety.

Keywords:

escitalopram, citalopram, 5-HT, dorsal raphe, hippocampus, 5-HT1A receptors

Extra navigation

.
ADVERTISEMENT